AAP
LUNG icon

Arax Advisory Partners’s Pulmonx LUNG Stock Holding History

Arax Advisory Partners’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.3K Buy
14,878
+14,875
+495,833% +$20.5K ﹤0.01% 3986
2026
Q1 		$23 Buy
+3
New +$5 ﹤0.01% 3706
2025
Q4 		– Sell
-1,420
Closed -$2.3K – 4343
2025
Q3 		$2.3K Buy
+1,420
New +$2.97K ﹤0.01% 3084
2025
Q2 		– Sell
-106
Closed -$714 – 3140
2025
Q1 		$714 Hold
106
– – ﹤0.01% 2437
2024
Q4 		$720 Buy
106
+13
+14% +$86 ﹤0.01% 2245
2024
Q3 		$771 Hold
93
– – ﹤0.01% 2324
2024
Q2 		$590 Buy
+93
New +$715 ﹤0.01% 2306

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Arax Advisory Partners's LUNG Position: Q2 2026 in Review

Arax Advisory Partners increased its Pulmonx (LUNG) stake by 495,833% in Q2 2026, buying an estimated $20.5K and bringing the position to 14,878 shares worth $19.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3986.

Arax Advisory Partners first reported a position in LUNG in Q2 2024 and has held it in 7 quarters since. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Arax Advisory Partners held 14,878 shares of Pulmonx worth $19.3K as of Q2 2026.
  • Arax Advisory Partners bought 14,875 Pulmonx shares in Q2 2026, an estimated $20.5K.
  • Pulmonx made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3986 holding.
  • Arax Advisory Partners first reported a position in Pulmonx in Q2 2024 and has held it in 7 quarters since.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.